Published in
Taylor and Francis Group, Journal of Medical Economics (JME), 2(21), p. 113-121, 2017
DOI: 10.1080/13696998.2017.1377718
Links
Tools
Cost-effectiveness of osimertinib in the UK for advanced EGFR-T790M non-small cell lung cancer
Journal article published in 2017 by
Evelina Bertranou,
Carolyn Bodnar,
Viktor Dansk,
Alastair Greystoke 
,
Samuel Large,
Matthew Dyer
,
Samuel Large,
Matthew Dyer
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 